Goal Directed Fluid Management , Pvi
Launched by BAKIRKOY DR. SADI KONUK RESEARCH AND TRAINING HOSPITAL · May 17, 2019
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
Objectives: The first objective of the investigators's study was to compare the liberal fluid management (LFM) with PVI guided goal-directed fluid management (GDFM) in terms of controlled intraoperative fluid volume, surgical end-point fluid balance, blood lactate and serum creatinine levels.
The investigators's secondary purpose was to compare the effects of different fluid regimens on the postoperative kidney injury and the duration of hospital stay.
Methods: The study included 112 American Society of Anesthesiologists (ASA) grade I ,ll and lll patients, aged above 18 and undergoing ele...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Gynecological oncologic cases
- • 2. Patients over 18 years old
- • 3. ASA 1-2-3 patients
- Exclusion Criteria:
- • 1. Patients with peripheral arterial disease
- • 2. Patients with non-sinus rhythm, arrhythmia, atrial fibrillation
- • 3. Patients with entry MAP \<65 mmHg
- • 4. Patients with advanced renal and hepatic impairment
- • 5. Mental retarded and non-cooperative patients
- • 6. Patients with advanced heart failure, EF \<30%
- • 7. Patients have massive bleeding in the perioperative period, need for massive transfusion
- • 8. Patients have acute pulmonary pathology
- • 9. Patients with anaphylaxis who developed a blood product reaction
- • 10. Patients who do not allow a tidal volume of 8ml / kg in a mechanical ventilator
About Bakirkoy Dr. Sadi Konuk Research And Training Hospital
Bakirkoy Dr. Sadi Konuk Research and Training Hospital is a leading healthcare institution dedicated to advancing medical research and education. Located in Istanbul, Turkey, the hospital combines clinical excellence with a robust research framework, focusing on innovative treatment methodologies and patient care. As a prominent clinical trial sponsor, it fosters collaboration among multidisciplinary teams to facilitate groundbreaking studies that enhance medical knowledge and improve health outcomes. The institution is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
güneş özlem yildiz
Principal Investigator
bakırköy Dr. Sadi Konuk Education hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials